These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36986625)

  • 21. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.
    Monschke M; Wagner KG
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
    Rahman M; Arevalo F; Coelho A; Bilgili E
    Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Spray-Dried Particle Morphology on Mechanical and Flow Properties of Felodipine in PVP VA Amorphous Solid Dispersions.
    Ekdahl A; Mudie D; Malewski D; Amidon G; Goodwin A
    J Pharm Sci; 2019 Nov; 108(11):3657-3666. PubMed ID: 31446144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A; Schiffter HA
    Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD; Pinto JF; Henriques J; Paiva AM
    Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and Characterization of Spray-Dried Hybrid Nanocrystal-Amorphous Solid Dispersions (HyNASDs) for Supersaturation Enhancement of a Slowly Crystallizing Drug.
    Rahman M; Radgman K; Tarabokija J; Ahmad S; Bilgili E
    Nanomaterials (Basel); 2023 Aug; 13(17):. PubMed ID: 37686927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions Via Noninvasive Imaging Analytics and Material Characterization.
    Jia W; Yawman PD; Pandya KM; Sluga K; Ng T; Kou D; Nagapudi K; Luner PE; Zhu A; Zhang S; Hou HH
    Pharm Res; 2022 Dec; 39(12):3137-3154. PubMed ID: 35661085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface nanocoating of high drug-loading spray-dried amorphous solid dispersions by atomic layer coating: Excellent physical stability under accelerated storage conditions for two years.
    Van Duong T; Nguyen HT; Wang F; Wang M; Narwankar PK; Taylor LS
    Int J Pharm; 2022 May; 620():121747. PubMed ID: 35427750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: Effect of formulation and process parameters for a low glass transition temperature drug.
    Kallakunta VR; Sarabu S; Bandari S; Batra A; Bi V; Durig T; Repka MA
    J Drug Deliv Sci Technol; 2020 Aug; 58():. PubMed ID: 32905375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1:1) and hydroxypropyl cellulose in ternary amorphous solid dispersions.
    Pöstges F; Kayser K; Stoyanov E; Wagner KG
    Int J Pharm X; 2022 Dec; 4():100115. PubMed ID: 35368508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.
    Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E
    Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a Three-Fluid Nozzle Spraying Process for Facilitating Spray Drying of Hydrophilic Polymers for the Creation of Amorphous Solid Dispersions.
    Mueller LK; Halstenberg L; Di Gallo N; Kipping T
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D; Zhu D; Zhou X; Dong S; Chen Y
    Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.